Core Viewpoint - DarioHealth Corp. and GreenKey Health have formed a strategic partnership to address the $150 billion sleep apnea market, which affects over 29 million Americans, by providing an integrated chronic care solution that combines behavioral health, sleep, and cardiometabolic care [1][4]. Group 1: Collaboration Details - The collaboration combines Dario's AI-powered health solutions with GreenKey's sleep-first approach to obstructive sleep apnea management [2]. - The immediate focus is on engaging large payers and building a national network of service providers through targeted outreach and thought leadership [3]. - The partnership aims to secure payer contracts and enhance awareness through a multi-channel marketing plan targeting various healthcare plans and self-funded employers [2][3]. Group 2: Market Opportunity - The sleep apnea market is significant, with up to 80% of moderate to severe cases undiagnosed, leading to over $150 billion in annual costs due to related health issues [4]. - There is a growing demand for integrated solutions as payers shift towards value-based care, which the collaboration aims to fulfill [4]. Group 3: Expected Outcomes - The joint solution is designed to improve member health outcomes, reduce healthcare costs, and increase productivity through better sleep health and effective comorbidity management [6]. - The collaboration is expected to provide actionable data insights to continuously optimize program performance [6]. - By aligning behavioral health and sleep strategies with cardiometabolic interventions, the partnership offers a comprehensive approach to chronic care management [5].